Michael Houghton

Michael Houghton

Director/Board Member at ASSEMBLY BIOSCIENCES, INC.

Net worth: 88 567 $ as of 31/05/2026

75 year
Health Technology
Consumer Services
Commercial Services

Profile

Michael Houghton is Chairman-Virology and Professor at the University of Alberta since 2010.
Director at Li Ka Shing Institute of Virology.
Independent Director at Assembly Biosciences, Inc. since 2021.
Director at Achlys, Inc., Prophysis, Inc., Aurora Vaccines, Inc., Heka Therapeutics, Inc., and Egerio, Inc. Former Vice President-Hepatitis C & Virology Research at Novartis Vaccines & Diagnostics, Inc. Chief Scientific Officer at Epiphany Biosciences, Inc. from 2007 to 2009.
Former Professor at the University of Alberta.
Educated at the University of East Anglia (undergraduate) and King's College London (doctorate).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 3,202 ( 0.02% ) 88 567 $ 31/05/2026

Michael Houghton active positions

CompaniesPositionStart
ASSEMBLY BIOSCIENCES, INC. Director/Board Member 19/07/2021
Director/Board Member -
Corporate Officer/Principal 01/01/2010
Achlys, Inc.
Director/Board Member -

Former positions of Michael Houghton

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/01/2009
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Michael Houghton's experience

Training of Michael Houghton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Achlys, Inc.

  1. Stock Market
  2. Insiders
  3. Michael Houghton
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!